Beijing Beilu Pharmaceutical Co.,Ltd.’s Net Profit Dropped 70.7% in First Quarter of 2023

Beijing Beilu Pharmaceutical Co.,Ltd. (北京北陆药业股份有限公司) (300016.SZ) reported a net profit of 10.2 million yuan in the first quarter of 2023, down 70.7% year-on-year.

Meanwhile, the company posted 188 million yuan in revenue, up 2.2% year-on-year.

At the end of the reporting period, it had 2.9 billion yuan in total assets and 943.7 million yuan in total liabilities, with a liability-to-asset ratio of 32.8%.